amantadine has been researched along with rimantadine in 292 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 54 (18.49) | 18.7374 |
| 1990's | 61 (20.89) | 18.2507 |
| 2000's | 95 (32.53) | 29.6817 |
| 2010's | 73 (25.00) | 24.3611 |
| 2020's | 9 (3.08) | 2.80 |
| Authors | Studies |
|---|---|
| Belshe, RB; Cerruti, RL; Connell, EV; Hill, CH; Keech, E; Manchand, PS; Martin, JA; Merrett, JH; Sim, IS | 1 |
| Andrei, G; Balzarini, J; De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Neyts, J; Padalko, E; Snoeck, R | 1 |
| De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Mavromoustakos, T; Tataridis, D | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| De Clercq, E; Foscolos, GB; Fytas, G; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingham, SR; Zoidis, G | 1 |
| De Clercq, E; Gawin, R; Koszytkowska-Stawińska, M; Naesens, L | 1 |
| Camins, A; Camps, P; Cortés, D; De Clercq, E; Duque, MD; Ivorra, D; Kelly, JM; López-Querol, M; Naesens, L; Pallàs, M; Prathalingam, SR; Romero, V; Sureda, FX; Vázquez, S | 1 |
| De Clercq, E; Kolocouris, N; Naesens, L; Zoidis, G | 1 |
| Camps, P; De Clercq, E; Duque, MD; Kelly, JM; López-Querol, M; Mallol, J; Montaner, S; Naesens, L; Prathalingam, SR; Profire, L; Sureda, FX; Vázquez, S | 1 |
| Balzarini, J; Brancale, A; Cirilli, R; Coluccia, A; Giordano, C; La Regina, G; La Torre, F; Lavecchia, A; Maga, G; Novellino, E; Piscitelli, F; Samuele, A; Sansone, A; Silvestri, R; Zanoli, S | 1 |
| Batta, G; Herczegh, P; Kéki, S; Komáromi, I; Mándi, A; Naesens, L; Ostorházi, E; Pintér, G; Röth, E; Rozgonyi, F; Sztaricskai, F; Takács-Novák, K | 1 |
| Camins, A; Camps, P; Duque, MD; Kelly, JM; López-Querol, M; Prathalingam, SR; Sureda, FX; Torres, E; Valverde, E; Vázquez, S | 1 |
| Batta, G; Bereczki, I; Boda, Z; Herczegh, P; Naesens, L; Ostorházi, E; Otvös, R; Pintér, G; Roth, E; Rozgonyi, F; Szarvas, M; Sztaricskai, F | 1 |
| Eleftheratos, S; Hay, A; Kolocouris, A; Martin, S; Martinelli, A; Ortore, G; Spearpoint, P | 1 |
| De Clercq, E; Ganguly, S; Kumar, KS; Veerasamy, R | 1 |
| De Clercq, E; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingam, SR; Zoidis, G | 1 |
| Balzarini, J; De Clercq, E; Dewan, SK; Kumar, P; Narasimhan, B; Pannecouque, C; Yadav, S | 1 |
| Codd, R; Liao, V; Lifa, T; Liu, J; Obando, D | 1 |
| Duque, MD; Kelly, JM; López-Querol, M; Ma, C; Naesens, L; Pinto, LH; Sureda, FX; Taylor, MC; Torres, E; Vázquez, S | 1 |
| Balzarini, J; Bharatam, PV; Chibale, K; Kaur, H; Little, S; Singh, K | 1 |
| Batta, G; Bereczki, I; Borbás, A; Fejes, Z; Herczegh, P; Kiss-Szikszai, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Török, Z | 1 |
| Cesur, N; Cesur, Z; Göktaş, F; Naesens, L; Vanderlinden, E | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Canturk, B; DeGrado, WF; Fiorin, G; Jo, H; Klein, ML; Lamb, RA; Ma, C; Pinto, LH; Wang, J | 1 |
| Balzarini, J; Chibale, K; Kaur, H; Singh, K | 1 |
| Balzarini, J; Singh, K | 1 |
| Barniol-Xicota, M; DeGrado, WF; Lamb, RA; Ma, C; Naesens, L; Pinto, LH; Rey-Carrizo, M; Torres, E; Vázquez, S; Wang, J; Wu, Y | 1 |
| Busath, DD; Cross, TA; Fedida, D; Johnson, FB; Kolocouris, A; Tietjen, I; Tzitzoglaki, C; Wright, AK; Zell, R | 1 |
| Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S | 1 |
| Batta, G; Bereczki, I; Borbás, A; Dobray, L; Herczegh, P; Kéki, S; Kicsák, M; Naesens, L; Nikodém, ÉN; Ostorházi, E; Rozgonyi, F; Vanderlinden, E | 1 |
| Batta, G; Bereczki, I; Borbás, A; Fizil, Á; Herczegh, P; Komáromi, I; Kurtán, T; Mándi, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Sztaricskai, F; Vanderlinden, E | 1 |
| Font-Bardia, M; Frigolé-Vivas, M; Gazzarrini, S; Juárez-Jiménez, J; Llabrés, S; Luque, FJ; Moroni, A; Naesens, L; Rey-Carrizo, M; Vázquez, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chizhov, AO; Geisman, AN; Khandazhinskaya, AL; Kochetkov, SN; Naesens, L; Novikov, MS; Ozerov, AA; Pannecouque, C; Seley-Radtke, KL; Valuev-Elliston, VT | 1 |
| Artyushin, OI; Brel, VK; Genkina, GK; Kadyrova, RA; Klemenkova, ZS; Moiseeva, AA; Orshanskaya, IR; Salakhutdinov, NF; Sharova, EV; Shtro, AA; Vinogradova, NM; Yarovaya, OI; Zarubaev, VV | 1 |
| Barniol-Xicota, M; Gazzarrini, S; Hu, Y; Moroni, A; Naesens, L; Torres, E; Vázquez, S; Wang, J | 1 |
| Cichero, E; Costi, MP; Gazzarrini, S; Loddo, R; Moroni, A; Naesens, L; Santucci, M; Tasso, B; Tonelli, M | 1 |
| Busath, DD; Drakopoulos, A; Freudenberger, K; Gauglitz, G; Hoffmann, A; Hutterer, J; Kolocouris, A; Kolokouris, D; Konstantinidi, A; Ma, C; McGuire, K; Schmidtke, M; Tzitzoglaki, C; Wang, J | 1 |
| Andrei, G; Pertusati, F; Pileggi, E; Schols, D; Serpi, M; Snoeck, R | 1 |
| Cichero, E; Costi, MP; Francesconi, V; Giordanetto, F; Giovannini, L; Naesens, L; Santucci, M; Tonelli, M | 1 |
| Orshanskaya, IR; Salakhutdinov, NF; Semenova, MD; Shtro, AA; Sokolova, AS; Yarovaya, OI; Zarubaev, VV | 1 |
| Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E | 1 |
| Bormotov, NI; Dorovatovskii, PV; Gatilov, YV; Khrustalev, VN; Kovaleva, KS; Novikov, RA; Salakhutdinov, NF; Shishkina, LN; Yarovaya, OI; Zarubaev, VV; Zubkov, FI | 1 |
| Kalra, S; Khatik, GL; Kumar, GN; Kumar, R; Narang, R; Nayak, SK; Singh, SK; Sudhakar, K | 1 |
| Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V | 1 |
| Borisevich, SS; Lantseva, K; Mainagashev, IY; Salakhutdinov, NF; Shtro, AA; Sokolova, AS; Volobueva, AS; Yarovaya, OI; Zarubaev, VV | 1 |
| Balzarini, J; De Clercq, E; Karki, SS; Kulkarni, AA; Kumar, S; Veliyath, SK | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Longuet, P; Vildé, JL | 1 |
| Arden, NH; Monto, AS | 1 |
| Bruu, AL; Orstavik, I | 1 |
| Grambas, S; Hay, AJ | 1 |
| Drinka, P; Gravenstein, S; Miller, BA | 1 |
| Hay, AJ; Hayden, FG | 1 |
| Newell, PM; Van Voris, LP | 1 |
| Douglas, RG | 2 |
| Hayden, FG | 8 |
| Gilbert, BE; Knight, V | 1 |
| Bean, B | 1 |
| Bryson, YJ | 1 |
| Johnson, DC | 1 |
| Steele, RW | 1 |
| Bricaire, F | 1 |
| Betts, RF | 1 |
| Belshe, RB; Burk, B; Cerruti, RL; Newman, F; Sim, IS | 1 |
| Dolin, R | 1 |
| Donath, E; Donath, J; el-Karadagi, S; Glaser, R; Herrmann, A; Kharitonenkov, IG; Lentzsch, P; Tverdislov, VA | 1 |
| Coakley, WT; Donath, E; Egger, M; Groth, T; Herrmann, A; Taeger, M | 1 |
| Donath, E; Egger, M; Glaser, R; Ziemer, S | 1 |
| Uhl, D | 1 |
| Blasecki, JW; Gaylord, JC; Hoffman, HE; Shalaby, LM; Whitney, CC | 1 |
| Hayden, FG; Tominack, RL | 1 |
| Spector, R | 1 |
| Cockerill, FR; Hermans, PE | 1 |
| Jannasch, R | 1 |
| Bean, WJ; Kawaoka, Y; Webster, RG | 1 |
| Hayden, FG; Hoffman, HE; Minocha, A; Spyker, DA | 1 |
| Galbraith, AW | 1 |
| Bean, WJ; Beard, CW; Brugh, M; Kawaoka, Y; Webster, RG | 1 |
| La Force, FM | 1 |
| Döhner, L; Mentel, R; Panzig, B; Seidel, W | 1 |
| Adamczyk, B; Heider, H; Richter, B | 1 |
| Adamczyk, B; Feldblum, R; Heider, H; Indulen, MK; Presber, HW; Schroeder, C | 1 |
| Nicholson, KG | 3 |
| Galasso, GJ | 1 |
| Yaar, I | 1 |
| White, DO | 1 |
| Togo, Y | 1 |
| Pert, CB; Quirion, R | 1 |
| Goldwater, PN | 1 |
| Field, HJ; Oxford, JS | 1 |
| Bucher, DJ; El Karadaghi, S; Kharitonenkov, IG; Tverdislov, VA; Zakomirdin, JA | 1 |
| Valenti, WM | 1 |
| Sebastiani, A | 1 |
| Garcia Gil, M; Sanchez Crespo, M | 1 |
| Hayden, FG; Hoffman, HE; Spyker, DA | 1 |
| Betts, RF; Christmas, WA; Douglas, RG; Hayden, FG; Van Voris, LP | 1 |
| Bryson, YJ; Dreisbach, M; Millet, VM | 1 |
| Kramer, MJ; Tilley, JW | 1 |
| Dolin, R; Linton, PN; Madore, HP; Maynard, R; Reichman, RC; Webber-Jones, J | 1 |
| Burlington, DB; Meiklejohn, G; Mostow, SR | 2 |
| Hovi, T | 1 |
| Cate, TR; Couch, RB; Goswick, CB; Quarles, JM | 1 |
| Adams, KF; Giordani, B; Gwaltney, JM; Hayden, FG; Van de Castle, RL | 1 |
| Cote, KM; Douglas, RG; Hayden, FG | 1 |
| Ford, CM; Hay, AJ; Schroeder, C; Wharton, SA | 1 |
| Pyhälä, R | 1 |
| Nahata, MC; Wintermeyer, SM | 1 |
| Bandy, U | 1 |
| Kuritzky, L | 1 |
| Cordier, JF; Philit, F | 1 |
| Cox, N; Hemphill, M; Hirsh, D; Houck, P; LaCroix, S | 1 |
| Serkedjieva, J; Zgorniak-Nowosielska, I | 1 |
| Guay, DR | 1 |
| Monto, AS | 3 |
| Morris, DJ | 1 |
| Rakestraw, D | 1 |
| Mahmood, W; Sacks, SL | 1 |
| Ahwesh, ER; Ruben, FL; Zimmerman, RK | 1 |
| Couch, RB | 2 |
| Shigeta, S | 1 |
| Merchant, GL; Mower, WR; Talan, DA | 1 |
| Drinka, PJ; Gravenstein, S; Krause, P; Miller, BA; Schilling, M; Shult, P | 1 |
| Margo, KL; Shaughnessy, AF | 1 |
| Gerstoft, J; Pedersen, C | 1 |
| Hayden, FG; Perelson, AS; Stilianakis, NI | 1 |
| Niederman, MS | 1 |
| Krapivin, SV; Morozov, IS; Sergeeva, SA | 1 |
| Atmar, RL; Champlin, RE; Cox, NJ; Englund, JA; Kantarjian, H; Klimov, AI; Regnery, H; Tarrand, J; Whimbey, E; Wyde, PR; Yousuf, H | 1 |
| Scholtissek, C; Webster, RG | 1 |
| Expósito Rivas, L; Goyenechea Hernández, A; Pérez Rodríguez, AE; Rodríguez Leyva, O | 1 |
| Mossad, SB | 2 |
| Silagy, CA | 1 |
| Reina, J | 1 |
| Perrillo, RP; Younossi, ZM | 1 |
| Ikejima, H; Kanemitsu, K; Shimada, J | 1 |
| Deeks, J; Demicheli, V; Jefferson, T; Rivetti, D | 2 |
| Butkiewicz, N; Hong, Z; Howe, AY; Jubin, R; Lau, JY; Murray, MG | 1 |
| Goldman, MP; Long, JK; Mossad, SB | 1 |
| Deeks, JJ; Demicheli, V; Jefferson, TO; Rivetti, D | 3 |
| Bertino, JS; Karl, M; Keyser, LA; Nafziger, AN | 1 |
| Ashley, JV; Gum, KD; Montalto, NJ | 1 |
| Rosen, DS | 1 |
| Fleming, DM | 1 |
| Bennett, M; Cameron, K; Cox, N; Gregory, V; Hall, H; Hay, A; Klimov, A; Lim, W; Lin, YP; Marozin, S | 1 |
| Hartshorn, KL; Kandel, R | 1 |
| Preboth, M | 1 |
| Holdiness, MR | 1 |
| Gross, PA | 1 |
| Havel, J; Pazourek, J; Polásková, P; Reichová, N | 1 |
| Johnston, SL | 1 |
| Farr, BM; Hall, KK; Hayden, FG; Salgado, CD | 1 |
| Cox, NJ; Fukuda, K; Uyeki, TM | 1 |
| Bridges, CB; Cox, NJ; Fukuda, K; Singleton, JA; Uyeki, TM | 1 |
| Prober, CG | 1 |
| Englund, JA | 1 |
| Carman, WF; Kerr, G; Stott, DJ | 1 |
| Uyeki, T; Winquist, A | 2 |
| Basler, CF; García-Sastre, A; Mikulasova, A; Palese, P; Swayne, DE; Taubenberger, JK; Tumpey, TM | 1 |
| Dumyati, G; Falsey, AR | 1 |
| Balasingam, S; Bossuyt, S; Lambkin, R; Mann, A; Novelli, P; Oxford, JS | 1 |
| Mitamura, K | 1 |
| Kirkbride, HA; Watson, J | 1 |
| Bellantonio, S; Rose, DN; Rothberg, MB | 1 |
| Marra, CA; Marra, F; Stiver, HG | 1 |
| Pegram, PS; Williamson, JC | 1 |
| Lu, Q | 1 |
| Härtl, A; Sauerbrei, A; Stelzner, A; Wutzler, P | 1 |
| Baddour, LM; Prabhu, RM; Smith, TF; Trampuz, A | 1 |
| Deeks, JJ; Demicheli, V; Jefferson, T; Rivetti, D; Rudin, M | 1 |
| Fagan, HB; Moeller, AH | 1 |
| Hansen, L | 2 |
| Drew, WL | 1 |
| Fujii, Y; Higashi, Y; Uemori, I | 1 |
| Gonzalez, MA; Lieberman, A; Papapetropoulos, S; Roberts, EL; Singer, C | 1 |
| Fujii, Y; Higashi, Y | 1 |
| Brandstaedt, A; Haertl, A; Sauerbrei, A; Schmidtke, M; Wutzler, P | 1 |
| Fujii, Y; Higashi, Y; Matsumura, H; Nakamura, S | 1 |
| Nau, JY | 1 |
| Demicheli, V; Di Pietrantonj, C; Jefferson, T; Rivetti, D | 1 |
| Chen, H; Cheung, CL; Guan, Y; Naipospos, TS; Peiris, JS; Rayner, JM; Smith, GJ; Wang, P; Webster, RG; Yuen, KY; Zhang, J | 1 |
| De Clercq, E | 1 |
| Cunha, BA | 1 |
| Hayden, FG; Pavia, AT | 1 |
| Brydak, LB; Gawryluk, D; Machała, M; Wiatr, E | 1 |
| Lynch, JP; Walsh, EE | 1 |
| Fang, F; Han, L; Ming, M; Shuangjin, C | 1 |
| Bright, RA; Cox, NJ; Deyde, VM; Gubareva, LV; Klimov, AI; Shaw, M; Shu, Y; Smith, CB; Xu, X; Zhang, Y | 1 |
| Wesseling, G | 1 |
| Alves da Cunha, AJ; Alves Galvão, MG; Rocha Crispino Santos, MA | 3 |
| Kelly, JM; Kolocouris, N; Papanastasiou, I; Prathalingam, SR; Tsotinis, A | 1 |
| Worrall, G | 1 |
| Nüesch, R | 1 |
| Aruksakunwong, O; Chuenpennit, K; Decha, P; Hannongbua, S; Intharathep, P; Kaiyawet, N; Laohpongspaisan, C; Loisruangsin, A; Malaisree, M; Pianwanit, S; Rungrotmongkol, T; Sompornpisut, P | 1 |
| Cameron, NA; Eggers, RR; Feldman, C; Green, RJ; Klugman, K; Lalloo, U; Madhi, SA; Phillips, D; Richards, GA; Schoub, B; Zar, HJ | 1 |
| De Clercq, E; Kelly, JM; Kolocouris, N; Naesens, L; Prathalingam, SR; Tsotinis, A; Zoidis, G | 1 |
| Griffin, S; Harris, M; Owsianka, AM; Patel, AH; Rowlands, D; Stgelais, C | 1 |
| Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B | 1 |
| Chou, KC; Du, QS; Huang, RB; Li, XM; Wang, CH | 1 |
| Banerjee, A; Eckels, PC; England, KM; Gamboni-Robertson, F; Gries, LM; Kelher, MR; Khan, SY; McLaughlin, NJ; Moore, EE; Silliman, CC | 1 |
| Oxford, JS | 1 |
| Trémolières, F | 1 |
| Greer, LG; McIntire, DD; Roberts, SW; Rogers, VL; Sheffield, JS; Wendel, GD | 1 |
| Dal Peraro, M; Devane, RH; Khurana, E; Klein, ML | 1 |
| Arkin, IT; Astrahan, P | 1 |
| Azad, TM; Gregory, V; Hay, A; Lin, YP; Yavarian, J; Zheng, X | 1 |
| Griffin, S; Harris, M; Lemon, SM; Rowlands, D; Weinman, SA; Wozniak, AL; Yi, M | 1 |
| Arkin, IT; Astrahan, P; Bennett, ER; Flitman-Tene, R; Gilon, C; Krugliak, M | 1 |
| Chou, JJ; Pielak, RM | 1 |
| Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ | 1 |
| Arkin, IT; Astrahan, P; Krugliak, M; Leonov, H | 1 |
| Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S | 1 |
| Al-Najjar, BO; Choi, SB; Le, L; Tran, L; Wahab, HA; Yusuf, M | 1 |
| Charman, SA; Couraud, PO; Kooijmans, SA; Mezhiselvam, MM; Morizzi, J; Nicolazzo, JA; Romero, IA; Senyschyn, D; Weksler, B | 1 |
| Akl, EA; Alonso-Coello, P; Brozek, J; Chen, YL; Cheung, A; Flottorp, SA; Hopkins, JP; Hovhannisyan, G; Hsu, J; Ivanova, L; Mustafa, R; Saeterdal, I; Santesso, N; Schünemann, HJ; Smaill, F; Tian, J; Uyeki, TM; Wong, AD | 1 |
| Chang, YX; Du, LM; Jing, X; Li, JF; Qin, YF; Wang, GQ; Wu, H | 1 |
| Chen, YC; Chen, YW; Chu, CC; Hung, CH; Wang, JJ | 1 |
| Li, G; Shen, H; Zhang, M; Zhang, Y | 1 |
| Chen, J; Klibanov, AM; Larson, AM | 1 |
| Cui, F; Ding, S; Li, J; Liu, X; Yan, H; Yang, D; Yun, H; Zhang, Z | 1 |
| Król, E; Rychłowska, M; Szewczyk, B | 1 |
| Leong, NJ; Mcintosh, MP; Prankerd, RJ; Shackleford, DM | 1 |
| Li, F; Ma, C; Wang, J | 1 |
| Peiris, JS; Perera, HK | 1 |
| Le, LT; Nguyen, HT; Van Nguyen, H | 1 |
| Bhardwaj, N; Fernandez, MV; Gopal, R; Greenbaum, BD; Krammer, F; Miller, E | 1 |
| Fry, AM; McKimm-Breschkin, JL | 1 |
| Chen, X; Fan, J; Li, Y; Lin, T; Liu, H; Liu, X | 1 |
| Ali, NKM; Breitinger, HA; Breitinger, U; Farag, NS | 1 |
| Qian, M; Wang, W; Xiao, C; Xu, J; Yang, H; Zhang, Q | 1 |
| Chen, D; Dai, M; Liu, Z; Pan, Y; Peng, D; Wang, X; Wang, Y; Wei, W; Yuan, Z | 1 |
| Chen, D; Miao, H; Wu, Y; Zhao, Y | 1 |
| Gilson, MK; Henriksen, NM; Kantonen, SA | 1 |
| Jia, Q; Li, D; Qian, Y; Qiu, J; Wang, X; Yang, S | 1 |
| Guo, QY; Huang, DL; Tian, CL; Wang, ZA; Zhang, LH; Zheng, JS; Zuo, C | 1 |
| Boeckler, FM; Breitinger, HG; Breitinger, U; Ma, C; Mandour, YM; Wang, J; Zlotos, DP | 1 |
| Busath, DD; Hill, JT; McGuire, KL | 1 |
| Ahmed, M; Ali, NKM; Breitinger, HG; Breitinger, U; El-Azizi, MA; Farag, NS | 1 |
| Liu, JX; Wang, JP; Wu, NP; Zhang, L; Zhang, T | 1 |
| Bukh, J; Fahnøe, U; Galli, A; Gammeltoft, KA; Gottwein, JM; Offersgaard, A; Ramirez, S; Zhou, Y | 1 |
| B Andreas, L; Becker, S; Bentzen, BH; Giller, K; Jeppesen, MG; Kledal, TN; Kolocouris, A; Mujezinovic, A; Rosenkilde, MM; Toft-Bertelsen, TL; Tzortzini, E; Xue, K | 1 |
| Kanda, T; Kogure, H; Moriyama, M; Okamoto, H; Sasaki-Tanaka, R; Shibata, T | 1 |
| Chen, Y; Ma, J; Zhang, M; Zhao, Y | 1 |
| Barchanska, H; Kostina-Bednarz, M; Płonka, J | 1 |
92 review(s) available for amantadine and rimantadine
| Article | Year |
|---|---|
The many faces of the adamantyl group in drug design.
Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Agents; Iron Chelating Agents; Iron Overload; Malaria; Solubility | 2011 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Recent advancements in mechanistic studies and structure activity relationship of F
Topics: Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Proton-Translocating ATPases; Structure-Activity Relationship | 2019 |
Implications of viral resistance to amantadine in control of influenza A.
Topics: Amantadine; Drug Resistance, Microbial; Humans; Influenza, Human; Rimantadine | 1992 |
Prevention and control of influenza A outbreaks in long-term care facilities.
Topics: Amantadine; Disease Outbreaks; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Long-Term Care; Rimantadine | 1992 |
Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine.
Topics: Amantadine; Animals; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Rimantadine; Virulence | 1992 |
Prophylaxis and treatment of influenza.
Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine | 1990 |
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases | 1985 |
Chemotherapy of respiratory viruses.
Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases | 1986 |
Respiratory pharmacology. Antiviral agents.
Topics: Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpesviridae Infections; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Vidarabine | 1986 |
Antiviral agents for respiratory infections.
Topics: Amantadine; Antiviral Agents; Child; Humans; Interferons; Respiratory Tract Infections; Ribavirin; Rimantadine; Virus Diseases | 1988 |
Amantadine and rimantadine for the prevention of influenza A.
Topics: Adamantane; Adult; Age Factors; Aged; Amantadine; Child; Humans; Influenza A virus; Influenza, Human; Rimantadine; Seasons; United States | 1989 |
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections.
Topics: Adamantane; Adult; Aged; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine | 1987 |
Influenza--recent developments in prophylaxis and treatment.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Administration, Oral; Aerosols; Amantadine; Humans; Influenza, Human; Interferon Type I; Phosphatidylethanolamines; Ribavirin; Rimantadine | 1985 |
Antiviral therapy. Respiratory infections, genital herpes, and herpetic keratitis.
Topics: Acyclovir; Adult; Amantadine; Antiviral Agents; Child; Female; Herpes Genitalis; Humans; Idoxuridine; Infant; Infant, Newborn; Influenza, Human; Keratitis, Dendritic; Male; Picornaviridae Infections; Recurrence; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1984 |
An assessment of antiviral drugs for the management of infectious diseases in humans.
Topics: Amantadine; Antiviral Agents; Ascorbic Acid; Dosage Forms; Drug Evaluation; Encephalitis; Hepatitis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Inosine Pranobex; Interferons; Levamisole; Rimantadine; Subacute Sclerosing Panencephalitis; Trifluridine; Virus Diseases | 1981 |
Antiviral drugs 1983.
Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1983 |
Antiviral chemotherapy.
Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Bromodeoxyuridine; Female; Hepatitis B; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; In Vitro Techniques; Interferons; Male; Neoplasms; Papillomaviridae; Respiratory Tract Infections; Ribavirin; Rimantadine; Tumor Virus Infections; Vidarabine | 1984 |
[Future of antifungal and antiviral agents. 2. Antiviral agents. b. Present status of chemotherapy of viral infections of the respiratory tract].
Topics: Amantadine; Antiviral Agents; Humans; Interferons; Respiratory Tract Infections; Ribavirin; Rimantadine; Virus Diseases | 1984 |
Properties of antiviral agents. 2.
Topics: Amantadine; Antiviral Agents; DNA Viruses; Female; Humans; Interferons; Ribavirin; Rimantadine; RNA Viruses; Virus Diseases | 1984 |
Antiviral drugs today.
Topics: Acyclovir; Administration, Topical; Adolescent; Amantadine; Antiviral Agents; Chickenpox; Child; Clinical Trials as Topic; Encephalitis; Female; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Keratitis, Dendritic; Male; Rimantadine; Vidarabine | 1984 |
Aminoadamantane derivatives.
Topics: Amantadine; Animals; Antiviral Agents; Humans; Memantine; Nervous System Diseases; Rimantadine | 1981 |
[Amantadine, rimantadine and influenza].
Topics: Amantadine; Humans; Influenza A virus; Ion Channels; Rimantadine; Viral Matrix Proteins | 1993 |
Rimantadine: a clinical perspective.
Topics: Absorption; Amantadine; Controlled Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Liver Diseases; Rimantadine | 1995 |
Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.
Topics: Aged; Amantadine; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Nursing Homes; Rimantadine | 1994 |
Using antiviral agents to control outbreaks of influenza A infection.
Topics: Aged; Amantadine; Disease Outbreaks; Homes for the Aged; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Nursing Homes; Rimantadine; Seasons | 1994 |
Adverse effects and drug interactions of clinical importance with antiviral drugs.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine | 1994 |
Viral respiratory infections in the community: epidemiology, agents, and interventions.
Topics: Adolescent; Adult; Age Factors; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Orthomyxoviridae; Picornaviridae Infections; Respiratory Tract Infections; Rhinovirus; Rimantadine; Virus Diseases | 1995 |
Anti-infective therapy for viral pneumonia.
Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine | 1995 |
Use of antivirals in influenza in the elderly: prophylaxis and therapy.
Topics: Aged; Amantadine; Antiviral Agents; Disease Outbreaks; Humans; Influenza, Human; Orthomyxoviridae; Rimantadine; Risk Factors; Treatment Outcome; Virus Replication | 1996 |
Antivirals for pandemic influenza.
Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Neuraminidase; Ribavirin; Rimantadine | 1997 |
Influenza, influenza vaccine, and amantadine/rimantadine.
Topics: Amantadine; Antiviral Agents; Contraindications; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccination | 1997 |
[Current status of research and development for anti-influenza virus drugs--chemotherapy for influenza].
Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Quinolizines; Rimantadine | 1997 |
Update on emerging infections from the Centers for Disease Control and Prevention. Influenza: ED considerations for the 1997-98 season.
Topics: Amantadine; Antiviral Agents; Emergency Medicine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine | 1997 |
Antiviral drugs in healthy children.
Topics: Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Child; Child, Preschool; Drug Administration Schedule; Herpes Simplex; Humans; Respiratory Syncytial Virus Infections; Ribavirin; Rimantadine; Virus Diseases | 1998 |
Strategies for prevention of community-acquired pneumonia.
Topics: Amantadine; Antiviral Agents; Community-Acquired Infections; Humans; Influenza Vaccines; Influenza, Human; Pneumonia; Rimantadine; Staphylococcal Vaccines | 1998 |
Underused options for preventing and treating influenza.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir | 1999 |
[Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Ribavirin; Rimantadine | 1999 |
The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C.
Topics: Amantadine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Rimantadine; RNA, Viral; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
[Neurotoxicity of antiviral agents].
Topics: Acyclovir; Amantadine; Antiviral Agents; Central Nervous System Diseases; Ganciclovir; Humans; Rimantadine; Vidarabine | 1999 |
Prevention and early treatment of influenza in healthy adults.
Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2000 |
Measures for control of influenza.
Topics: Amantadine; Amines; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 1999 |
Cochrane reviews and systematic reviews of economic evaluations. Amantadine and rimantadine in the prevention and treatment of influenza.
Topics: Adult; Amantadine; Antiviral Agents; Cost of Illness; Humans; Influenza, Human; Rimantadine; United Kingdom | 1999 |
Antiviral agents for treating influenza.
Topics: Acetamides; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2000 |
Amantadine and rimantadine for preventing and treating influenza A in adults.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Rimantadine | 2000 |
Prevention and treatment of influenza in immunocompromised patients.
Topics: Aerosols; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Immunocompromised Host; Influenza Vaccines; Influenza, Human; Infusions, Intravenous; Organ Transplantation; Orthomyxoviridae; Primary Prevention; Ribavirin; Rimantadine | 1997 |
Updated treatment for influenza A and B.
Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir | 2000 |
Managing influenza: amantadine, rimantadine and beyond.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2001 |
Amantadine and rimantadine for preventing and treating influenza A in adults.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine | 2001 |
Prophylaxis and treatment of influenza virus infection.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Neuraminidase; Orthomyxoviridae Infections; Rimantadine; Vaccination | 2001 |
Adverse cutaneous reactions to influenza vaccinations and chemotherapy.
Topics: Acetamides; Amantadine; Antiviral Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Skin; Zanamivir | 2001 |
Vaccines for pneumonia and new antiviral therapies.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir | 2001 |
Perspectives on antiviral use during pandemic influenza.
Topics: Acetamides; Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Multiple, Viral; Drug Tolerance; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2001 |
Anti-influenza therapies.
Topics: Amantadine; Antiviral Agents; Humans; Influenza, Human; Neuraminidase; Rimantadine | 2002 |
Influenza in the acute hospital setting.
Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir | 2002 |
Antiviral therapy for influenza virus infections.
Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Global Health; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2002 |
Antiviral therapy of influenza.
Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Guanidines; Humans; Infant; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2002 |
Amantadine and rimantadine for preventing and treating influenza A in adults.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine | 2002 |
Nosocomial transmission of influenza.
Topics: Aged; Amantadine; Antiviral Agents; Cross Infection; Health Personnel; Humans; Influenza Vaccines; Influenza, Human; Long-Term Care; Rimantadine | 2002 |
Influenza.
Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir | 2002 |
Antivirals for influenza: what is their role in the older patient?
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2002 |
Reduction of the influenza burden in children.
Topics: Adolescent; Adult; Amantadine; Child; Comorbidity; Cost of Illness; Evidence-Based Medicine; Female; Humans; Immunization Schedule; Infant; Influenza Vaccines; Influenza, Human; Length of Stay; Neuraminidase; Otitis Media; Pneumonia, Pneumococcal; Pregnancy; Rimantadine; United States | 2002 |
Influenza.
Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Humans; Influenza, Human; Rimantadine; Sialic Acids | 2002 |
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Endemic Diseases; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir | 2003 |
[Antiviral agents for influenza].
Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir | 2003 |
Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Health Planning; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2003 |
A case for rimantadine to be marketed in Canada for prophylaxis of influenza A virus infection.
Topics: Amantadine; Antiviral Agents; Canada; Data Interpretation, Statistical; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine | 2003 |
Neuraminidase inhibitors in patients with underlying airways disease.
Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir | 2002 |
Avian influenza: a new pandemic threat?
Topics: Amantadine; Animals; Antiviral Agents; Asia; Communicable Diseases, Emerging; Disease Outbreaks; Drug Resistance, Multiple, Viral; Family Characteristics; Forecasting; Global Health; Humans; Influenza A virus; Influenza in Birds; Mutation; Neuraminidase; Patient Isolation; Population Surveillance; Poultry; Poultry Diseases; Recombination, Genetic; Rimantadine; Vaccination; Zoonoses | 2004 |
Amantadine and rimantadine for preventing and treating influenza A in adults.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine | 2004 |
What is the best antiviral agent for influenza infection?
Topics: Acetamides; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Contraindications; Evidence-Based Medicine; Family Practice; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2004 |
Influenza.
Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2003 |
Pandemic influenza: is an antiviral response realistic?
Topics: Amantadine; Antiviral Agents; Disaster Planning; Disease Outbreaks; Drug Resistance, Viral; Health Services Accessibility; Humans; Influenza, Human; Rimantadine; United States | 2004 |
Influenza.
Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2004 |
Amantadine and rimantadine for influenza A in adults.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Drug Administration Schedule; Emergencies; Humans; Influenza A virus; Influenza, Human; Middle Aged; Randomized Controlled Trials as Topic; Rimantadine; Virus Shedding | 2006 |
Which agents should we use to treat and prevent influenza in 2006-2007?
Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir | 2006 |
Antiviral therapy and prophylaxis for influenza in children.
Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir | 2007 |
Influenza: evolving strategies in treatment and prevention.
Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir | 2007 |
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir | 2007 |
Amantadine and rimantadine for influenza A in children and the elderly.
Topics: Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors | 2008 |
[Antiviral treatment of influenza in humans].
Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Virus Replication; Virus Shedding; Zanamivir | 2007 |
Influenza guideline for South Africa--update 2008.
Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine; South Africa; Vaccination | 2008 |
Antivirals for the treatment and prevention of epidemic and pandemic influenza.
Topics: Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir | 2007 |
Resistance characteristics of influenza to amino-adamantyls.
Topics: Adamantane; Amantadine; Amino Acid Sequence; Drug Resistance, Viral; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Ion Channels; Models, Molecular; Molecular Sequence Data; Mutation; Protein Stability; Protein Structure, Tertiary; Rimantadine; Sequence Homology, Amino Acid; Viral Matrix Proteins | 2011 |
Flu channel drug resistance: a tale of two sites.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Genes, Viral; Humans; Influenza A virus; Influenza B virus; Ion Channels; Models, Molecular; Mutation; Protein Structure, Tertiary; Rimantadine; Viral Matrix Proteins; Viral Proteins | 2010 |
[Research progress of anti-influenza virus agents].
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir | 2010 |
Antiviral drugs for influenza.
Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir | 2012 |
Amantadine and rimantadine for influenza A in children and the elderly.
Topics: Adolescent; Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors; Young Adult | 2012 |
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
Topics: Administration, Inhalation; Administration, Oral; Amantadine; Antiviral Agents; Confounding Factors, Epidemiologic; Hospitalization; Humans; Influenza, Human; Oseltamivir; Rimantadine; Treatment Outcome; Zanamivir | 2012 |
Antivirals--current trends in fighting influenza.
Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Viral Matrix Proteins; Zanamivir | 2014 |
Amantadine and rimantadine for influenza A in children and the elderly.
Topics: Adolescent; Aged; Amantadine; Antiviral Agents; Child; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Randomized Controlled Trials as Topic; Rimantadine; Sex Factors; Young Adult | 2014 |
Inhibitors targeting the influenza virus hemagglutinin.
Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Hemagglutinin Glycoproteins, Influenza Virus; Neuraminidase; Orthomyxoviridae; Oseltamivir; Rimantadine; Zanamivir | 2015 |
12 trial(s) available for amantadine and rimantadine
| Article | Year |
|---|---|
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Topics: Adult; Amantadine; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Interferons; Middle Aged; Picornaviridae Infections; Respiratory Tract Infections; Respirovirus Infections; Rhinovirus; Ribavirin; Rimantadine; Virus Diseases | 1985 |
Chemotherapy of respiratory viruses.
Topics: Acyclovir; Adult; Amantadine; Animals; Antiviral Agents; Benzimidazoles; Child; Clinical Trials as Topic; Female; Humans; Influenza, Human; Interferons; Oximes; Pneumonia, Viral; Respiratory Tract Infections; Ribavirin; Rimantadine; Sulfonamides; Vidarabine; Virus Diseases | 1986 |
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases | 1985 |
Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults.
Topics: Adamantane; Adult; Aged; Amantadine; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Mucus; Nasal Mucosa; Rimantadine | 1985 |
Antiviral drugs 1983.
Topics: Acyclovir; Amantadine; Antiviral Agents; Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Simplex; Humans; Idoxuridine; Influenza, Human; Interferons; Keratitis, Dendritic; Male; Ribavirin; Rimantadine; Trifluridine; Vidarabine | 1983 |
Antiviral drugs today.
Topics: Acyclovir; Administration, Topical; Adolescent; Amantadine; Antiviral Agents; Chickenpox; Child; Clinical Trials as Topic; Encephalitis; Female; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; Influenza, Human; Keratitis, Dendritic; Male; Rimantadine; Vidarabine | 1984 |
Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics.
Topics: Adamantane; Adult; Amantadine; Central Nervous System; Digestive System; Humans; Kinetics; Middle Aged; Rimantadine; Sleep | 1983 |
Successful treatment of naturally occurring influenza A/USSR/77 H1N1.
Topics: Adult; Amantadine; Central Nervous System; Clinical Trials as Topic; Double-Blind Method; Humans; Infant, Newborn; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza, Human; Rimantadine | 1981 |
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine.
Topics: Adamantane; Adolescent; Adult; Amantadine; Central Nervous System; Chlorpheniramine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Rimantadine | 1982 |
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection.
Topics: Adamantane; Adolescent; Adult; Amantadine; Clinical Trials as Topic; Humans; Infant, Newborn; Influenza A virus; Influenza, Human; Middle Aged; Patient Compliance; Random Allocation; Rimantadine | 1982 |
Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults.
Topics: Adamantane; Adult; Amantadine; Central Nervous System Diseases; Gastrointestinal Diseases; Humans; Motor Skills; Rimantadine; Sleep Wake Disorders; Time Factors | 1981 |
Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: report of a case series.
Topics: Aged; Amantadine; Antiparkinson Agents; Edema; Female; Humans; Middle Aged; Motor Activity; Parkinson Disease; Rimantadine; Severity of Illness Index | 2005 |
192 other study(ies) available for amantadine and rimantadine
| Article | Year |
|---|---|
Synthesis and antiviral activity of metabolites of rimantadine.
Topics: Adamantane; Animals; Antiviral Agents; Cell Line; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Structure; Rimantadine; Structure-Activity Relationship | 1990 |
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
Topics: Adamantane; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Dogs; Enterovirus B, Human; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Reoviridae; Semliki forest virus; Sindbis Virus; Structure-Activity Relationship; Vaccinia virus; Vesicular stomatitis Indiana virus | 1996 |
Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus A activity relationship study using a combination of NMR spectroscopy and molecular modeling.
Topics: Animals; Antiviral Agents; Cell Line; Dogs; Influenza A virus; Magnetic Resonance Spectroscopy; Models, Molecular; Piperidines | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Design and synthesis of bioactive adamantane spiro heterocycles.
Topics: Adamantane; Animals; Antiprotozoal Agents; Antiviral Agents; Heterocyclic Compounds; Influenza A virus; Leishmania; Trypanosoma | 2007 |
Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure.
Topics: Animals; Antiviral Agents; Aza Compounds; Catalysis; Cell Line; DNA Viruses; Drug Resistance, Viral; Humans; Hydrogenation; Nucleosides; Palladium; Pyrimidine Nucleosides; RNA Viruses; Structure-Activity Relationship; Sulfanilamide; Sulfanilamides | 2008 |
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs.
Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Dopamine; Influenza A virus; Inhibitory Concentration 50; Receptors, N-Methyl-D-Aspartate | 2008 |
Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
Topics: Adamantane; Animals; Antiviral Agents; Dogs; Humans; Influenza A Virus, H3N2 Subtype; Magnetic Resonance Spectroscopy; Molecular Structure; Piperidines; Rimantadine; Structure-Activity Relationship | 2009 |
Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.
Topics: Adamantane; Amines; Animals; Antiviral Agents; Cell Culture Techniques; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents | 2009 |
Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
Topics: Amino Acids; Animals; Anti-HIV Agents; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Drug Resistance, Viral; Enterovirus B, Human; HIV Reverse Transcriptase; HIV-1; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Lymphocytes; Mice; Models, Molecular; Molecular Conformation; Mutation; Protein Binding; Reverse Transcriptase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Sulfones; Virus Replication | 2009 |
Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
Topics: Anti-Bacterial Agents; Antiviral Agents; Diazonium Compounds; Doxorubicin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Orthomyxoviridae; Teicoplanin | 2009 |
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neurons; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2010 |
Click reaction synthesis of carbohydrate derivatives from ristocetin aglycon with antibacterial and antiviral activity.
Topics: Anti-Bacterial Agents; Antiviral Agents; Catalysis; Copper; Doxorubicin; Humans; Influenza A Virus, H1N1 Subtype; Microbial Sensitivity Tests; Ristocetin | 2010 |
Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model.
Topics: Adamantane; Amino Acid Sequence; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Sequence Data; Viral Matrix Proteins | 2010 |
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.
Topics: Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Schiff Bases; Spectrophotometry, Infrared | 2010 |
Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
Topics: Adamantane; Alcohols; Amines; Animals; Antiviral Agents; Drug Design; Influenza A virus; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Trypanosoma brucei brucei | 2010 |
4-[1-(Substituted aryl/alkyl carbonyl)-benzoimidazol-2-yl]-benzenesulfonic acids: synthesis, antimicrobial activity, QSAR studies, and antiviral evaluation.
Topics: Animals; Anti-Infective Agents; Benzenesulfonates; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Dogs; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Quantitative Structure-Activity Relationship; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses | 2010 |
Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.
Topics: Amines; Antiviral Agents; DNA Viruses; Humans; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei | 2012 |
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies.
Topics: Aminoquinolines; Animals; Antimalarials; Cell Line; DNA; Dogs; Heme; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Protoporphyrins; Pyrimidines; Structure-Activity Relationship; Viruses | 2012 |
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Drug Resistance, Viral; Gram-Positive Bacteria; Herpesvirus 1, Human; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Isoindoles; Microbial Sensitivity Tests; o-Phthalaldehyde; Teicoplanin | 2012 |
Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives.
Topics: Adamantane; Amides; Animals; Antiviral Agents; Aza Compounds; Chickens; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Microwaves; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Virus Replication | 2012 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
Topics: Antiviral Agents; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Mutation; Structure-Activity Relationship; Viral Matrix Proteins | 2013 |
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies.
Topics: Antimalarials; Antiviral Agents; Cell Line; Chemistry Techniques, Synthetic; DNA; Heme; Humans; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship | 2013 |
Regioselective synthesis of 6-substituted-2-amino-5-bromo-4(3H)-pyrimidinones and evaluation of their antiviral activity.
Topics: Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Dogs; Dose-Response Relationship, Drug; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidinones; Stereoisomerism; Structure-Activity Relationship; Vero Cells; Viruses | 2013 |
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
Topics: Amantadine; Animals; Antiviral Agents; Aza Compounds; Bridged-Ring Compounds; Dogs; Drug Design; Drug Resistance, Viral; Guanidines; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Mutation; Pyrrolidines; Structure-Activity Relationship; Viral Matrix Proteins | 2013 |
Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A.
Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Multiple, Viral; HEK293 Cells; Humans; Influenza A Virus, H1N1 Subtype; Ion Channels; Madin Darby Canine Kidney Cells; Mutation; Rimantadine; Viral Matrix Proteins | 2014 |
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds.
Topics: | 2012 |
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
Topics: Animals; Antiviral Agents; Binding Sites; Dogs; Dose-Response Relationship, Drug; Lipid Bilayers; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Structure-Activity Relationship; Teicoplanin | 2014 |
A few atoms make the difference: synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives.
Topics: Anti-Bacterial Agents; Antiviral Agents; Chemistry Techniques, Synthetic; Circular Dichroism; Computer Simulation; Magnetic Resonance Spectroscopy; Orthomyxoviridae; Protein Conformation; Ristocetin; Structure-Activity Relationship; Teicoplanin | 2015 |
New polycyclic dual inhibitors of the wild type and the V27A mutant M2 channel of the influenza A virus with unexpected binding mode.
Topics: Animals; Antiviral Agents; Binding Sites; Cell Survival; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; Influenza A virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mutation; Polycyclic Compounds; Structure-Activity Relationship; Viral Matrix Proteins | 2015 |
1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus.
Topics: Animals; Antiviral Agents; Cells, Cultured; Dogs; Dose-Response Relationship, Drug; HIV-1; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Uracil | 2016 |
Synthesis of camphecene derivatives using click chemistry methodology and study of their antiviral activity.
Topics: Animals; Antiviral Agents; Camphor; Click Chemistry; Dogs; Ethanolamines; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Structure-Activity Relationship | 2017 |
Slow but Steady Wins the Race: Dissimilarities among New Dual Inhibitors of the Wild-Type and the V27A Mutant M2 Channels of Influenza A Virus.
Topics: Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Influenza A virus; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Mutation; Patch-Clamp Techniques | 2017 |
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus.
Topics: Antiviral Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proguanil; Respiratory Syncytial Viruses; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2017 |
Unraveling the Binding, Proton Blockage, and Inhibition of Influenza M2 WT and S31N by Rimantadine Variants.
Topics: | 2018 |
Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs.
Topics: Antiviral Agents; Cell Line; DNA Viruses; Drug Stability; Humans; Nucleosides; Organophosphonates; Prodrugs; RNA Viruses; Structure-Activity Relationship | 2018 |
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
Topics: Antiviral Agents; Aza Compounds; Dose-Response Relationship, Drug; Folic Acid Antagonists; Models, Molecular; Molecular Structure; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines | 2018 |
Synthesis and
Topics: | 2017 |
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin | 2018 |
Synthesis of d-(+)-camphor-based
Topics: | 2018 |
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses | 2019 |
Synthesis and structure-activity relationships of novel camphecene analogues as anti-influenza agents.
Topics: Camphor; Ethanolamines; Humans; Influenza, Human; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-
Topics: | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Prophylaxis of influenza. Vaccination and chemoprophylaxis].
Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine | 1992 |
[Amantadine and rimantadine against influenza A].
Topics: Amantadine; Clinical Trials as Topic; Humans; Influenza A virus; Influenza, Human; Norway; Rimantadine | 1992 |
Maturation of influenza A virus hemagglutinin--estimates of the pH encountered during transport and its regulation by the M2 protein.
Topics: Amantadine; Animals; Biological Transport; Cell Line; Genes, Viral; Genetic Complementation Test; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins, Viral; Hydrogen-Ion Concentration; Influenza A virus; Mutation; Rimantadine; Viral Matrix Proteins | 1992 |
Antivirals for the chemoprophylaxis and treatment of influenza.
Topics: Administration, Intranasal; Administration, Oral; Amantadine; Drug Resistance; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Ribavirin; Rimantadine | 1992 |
Prevention and control of influenza recommendations of the Immunization Practices Advisory Committee (ACIP).
Topics: Adolescent; Adult; Aged; Amantadine; Child; Child, Preschool; Disease Outbreaks; Female; HIV Infections; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Pregnancy; Pregnancy Complications, Infectious; Rimantadine | 1991 |
Antiviral therapy. New drugs and their uses.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Common Cold; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Thymidine; Vidarabine; Virus Diseases; Zidovudine | 1986 |
Antiviral drugs for common respiratory diseases. What's here, what's to come.
Topics: Adult; Aged; Amantadine; Antiviral Agents; Child; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Interferons; Paramyxoviridae Infections; Pneumonia, Viral; Pregnancy; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin; Rimantadine; Virus Diseases | 1988 |
[Prevention of influenza].
Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine | 1989 |
Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
Topics: Adamantane; Amantadine; Animals; Antigens, Viral; Cell Line; Cytopathogenic Effect, Viral; Dogs; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Influenza A virus; Influenza, Human; Rimantadine; Viral Plaque Assay | 1989 |
Interaction of the antivirus agents remantadine and amantadine with lipid membranes and the influence on the curvature of human red cells.
Topics: Adamantane; Amantadine; Elasticity; Electron Spin Resonance Spectroscopy; Erythrocyte Deformability; Humans; Intracellular Membranes; Membrane Lipids; Rimantadine; Time Factors | 1986 |
The influence of the antiviral drugs amantadine and rimantadine on erythrocyte and platelet membranes and its comparison with that of tetracaine.
Topics: Adamantane; Amantadine; Antiviral Agents; Blood Platelets; Cell Fractionation; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Hemagglutination, Viral; Humans; Osmotic Fragility; Platelet Aggregation; Rimantadine; Tetracaine | 1987 |
Electrorotation--a new method for investigating membrane events during thrombocyte activation. Influence of drugs and osmotic pressure.
Topics: Adamantane; Amantadine; Blood Platelets; Calcimycin; Cell Membrane; Chlorpromazine; Electrochemistry; Humans; Light; Mathematics; Osmotic Pressure; Platelet Aggregation; Rimantadine; Scattering, Radiation; Thrombin | 1986 |
[Influenza virus infection. Influenza preventive vaccination and chemoprevention].
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Risk Factors | 1988 |
Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs.
Topics: Adamantane; Administration, Oral; Amantadine; Animals; Biological Availability; Dogs; Dose-Response Relationship, Drug; Feces; Female; Gas Chromatography-Mass Spectrometry; Lung; Metabolic Clearance Rate; Mice; Orthomyxoviridae Infections; Rimantadine | 1988 |
Transport of amantadine and rimantadine through the blood-brain barrier.
Topics: Adamantane; Amantadine; Animals; Biological Transport; Blood-Brain Barrier; Perfusion; Rats; Rats, Inbred Strains; Rimantadine | 1988 |
Antiviral agents.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Ganciclovir; Herpes Simplex; Humans; Idoxuridine; Influenza A virus; Influenza, Human; Ribavirin; Rimantadine; Thymidine; Vidarabine; Viruses; Zidovudine | 1987 |
[Capillary isotachophoresis--a new method in drug analysis. 3. Analytic capillary isotachophoresis for the determination of amantadine and rimantadine].
Topics: Adamantane; Amantadine; Capsules; Electrophoresis; Rimantadine; Spectrophotometry, Ultraviolet; Tablets | 1986 |
Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
Topics: Adamantane; Amantadine; Animals; Drug Resistance, Microbial; Influenza A virus; Influenza A Virus, H5N2 Subtype; Influenza Vaccines; Orthomyxoviridae Infections; Poultry; Poultry Diseases; Rimantadine; Vaccination | 1986 |
Combinations of antiviral agents for treatment of influenza virus infections.
Topics: Amantadine; Animals; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Orthomyxoviridae Infections; Ribavirin; Rimantadine | 1986 |
Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting.
Topics: Adamantane; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine | 1985 |
Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus.
Topics: Adamantane; Amantadine; Animals; Chickens; Drug Resistance, Microbial; Influenza A virus; Influenza in Birds; Rimantadine; Vaccination; Viral Vaccines | 1985 |
Community-acquired lower respiratory tract infections. Prevention and cost-control strategies.
Topics: Amantadine; Cost Control; Cross Infection; Humans; Influenza Vaccines; Influenza, Human; Pneumonia; Rimantadine; Sputum; Streptococcus pneumoniae; Vaccines | 1985 |
[Action of antiviral substances on influenza viruses through the inhibition of neuraminidase production].
Topics: Adamantane; Amantadine; Animals; Chick Embryo; Culture Techniques; Fibroblasts; Influenza A virus; Neuraminidase; Rimantadine | 1985 |
Evaluation of antiviral substances against influenza A virus strains by the haemadsorption reduction test.
Topics: Amantadine; Antiviral Agents; Deoxyglucose; Drug Evaluation, Preclinical; Hemadsorption Inhibition Tests; Influenza A virus; Microbiological Techniques; Ribavirin; Rimantadine | 1980 |
Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
Topics: Adamantane; Amantadine; Drug Resistance, Microbial; Humans; Influenza A virus; Mutation; Rimantadine | 1981 |
The effects of amantadine, rimantadine and levodopa on the frequency of fibrillation potentials in denervated muscle.
Topics: Acetylcholine; Adamantane; Amantadine; Animals; Electromyography; Levodopa; Muscle Contraction; Muscle Denervation; Rats; Receptors, Cholinergic; Rimantadine | 1984 |
Amantadine modulates phencyclidine binding site sensitivity in rat brain.
Topics: Amantadine; Animals; Brain; Olfactory Bulb; Phencyclidine; Rats; Receptors, Drug; Receptors, Phencyclidine; Rimantadine | 1982 |
New laboratory and clinical aspects of antiviral compounds. Introduction: a virological prescript.
Topics: Amantadine; Antiviral Agents; Humans; Rimantadine | 1984 |
Interaction of influenza virus proteins with planar bilayer lipid membranes. II. Effects of rimantadine and amantadine.
Topics: Adamantane; Amantadine; Dose-Response Relationship, Drug; Kinetics; Lipid Bilayers; Membrane Potentials; Phosphatidylcholines; Phospholipids; Rimantadine; Viral Matrix Proteins; Viral Proteins | 1984 |
Influenza: prevention and therapy.
Topics: Amantadine; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccination | 1984 |
[Amantadine and riamantadine in the treatment of influenza].
Topics: Adamantane; Amantadine; Humans; Influenza, Human; Rimantadine | 1983 |
Dansylcadaverine and rimantadine inhibition of phagocytosis, PAF-acether release, and phosphatidylcholine synthesis in human polymorphonuclear leukocytes.
Topics: Adamantane; Amantadine; Antineoplastic Agents; Cadaverine; Diamines; Humans; Neutrophils; Phagocytosis; Phosphatidylcholines; Platelet Activating Factor; Rimantadine | 1983 |
Anti-influenza A virus activity of amantadine hydrochloride and rimantadine hydrochloride in ferret tracheal ciliated epithelium.
Topics: Adamantane; Amantadine; Animals; Cilia; Cytopathogenic Effect, Viral; Epithelium; Ferrets; In Vitro Techniques; Influenza A virus; Rimantadine; Time Factors; Trachea; Virus Cultivation | 1982 |
Toxicity of amantadine and rimantadine for the ciliated epithelium of ferret tracheal rings.
Topics: Adamantane; Amantadine; Animals; Cilia; Ferrets; In Vitro Techniques; Rimantadine; Trachea | 1981 |
Adamantine influenza and the adamantanes.
Topics: Amantadine; Humans; Influenza, Human; Orthomyxoviridae; Rimantadine | 1981 |
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
Topics: Adamantane; Adolescent; Adult; Age Factors; Amantadine; Antibodies, Viral; Double-Blind Method; Drug Evaluation; Female; Humans; Influenza A virus; Influenza, Human; Male; Rimantadine | 1981 |
Plaque inhibition assay for drug susceptibility testing of influenza viruses.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Humans; Influenza, Human; Microbial Sensitivity Tests; Orthomyxoviridae; Ribavirin; Rimantadine; Time Factors; Viral Plaque Assay | 1980 |
Functional reconstitution in lipid vesicles of influenza virus M2 protein expressed by baculovirus: evidence for proton transfer activity.
Topics: Amantadine; Animals; Arylsulfonates; Cell Line; Fluorescent Dyes; Gene Expression Regulation, Viral; Genetic Vectors; Hydrogen-Ion Concentration; Influenza A virus; Ion Channels; Liposomes; Molecular Weight; Nucleopolyhedroviruses; Phosphorylation; Protein Conformation; Protons; Recombinant Fusion Proteins; Rimantadine; Spodoptera; Viral Matrix Proteins | 1994 |
ACIP updates recommendations for the use of antiviral agents in influenza. Advisory Committee on Immunization Practices.
Topics: Amantadine; Humans; Influenza, Human; Rimantadine | 1995 |
Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
Topics: Amantadine; Antiviral Agents; Humans; Immunization Schedule; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine; Vaccines, Inactivated | 1995 |
Influenza: prevention and control.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Child, Preschool; Female; Humans; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rhode Island; Rimantadine; Risk Factors | 1994 |
Annualizing our approach to influenza.
Topics: Adult; Aged; Amantadine; Child; Diagnosis, Differential; Humans; Influenza Vaccines; Influenza, Human; Male; Rimantadine | 1995 |
Therapeutic approaches of clinicians to influenza pandemic.
Topics: Adolescent; Adult; Aged; Amantadine; Child; Disease Outbreaks; Female; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Pregnancy; Rimantadine; Risk Factors; Vaccination | 1994 |
Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use.
Topics: Adult; Aged; Aged, 80 and over; Amantadine; Base Sequence; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Molecular Sequence Data; Nursing Homes; Rimantadine; Treatment Failure; Washington | 1995 |
Combined antiinfluenza activity of a plant preparation SHS-174 and amantadine derivatives.
Topics: Amantadine; Animals; Chick Embryo; Drug Interactions; Orthomyxoviridae; Plant Extracts; Rimantadine; Virus Replication | 1993 |
Drugs for non-HIV viral infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases | 1994 |
Determination of amantadine in human plasma by capillary gas chromatography using electron-capture detection following derivatization with pentafluorobenzoyl chloride.
Topics: Administration, Oral; Adult; Amantadine; Benzoates; Chromatography, Gas; Humans; Hydrogen-Ion Concentration; Male; Reference Standards; Reproducibility of Results; Rimantadine; Sensitivity and Specificity; Therapeutic Equivalency; Toluene | 1993 |
Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Drug Interactions; Female; Humans; Immunization Programs; Immunization Schedule; Infant; Infection Control; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine; Risk Factors; United States; Vaccination; Vaccines, Inactivated | 1996 |
ACIP issues recommendations for the prevention and control of influenza in the 1996-97 season.
Topics: Amantadine; Antiviral Agents; Contraindications; Humans; Immunization Programs; Influenza Vaccines; Influenza, Human; Premedication; Rimantadine; Seasons; United States | 1996 |
Combination antiviral therapy for respiratory virus infections.
Topics: Amantadine; Animals; Antiviral Agents; Common Cold; Drug Therapy, Combination; Humans; Influenza, Human; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Ribavirin; Rimantadine | 1996 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Breast Feeding; Child; Child, Preschool; Contraindications; Cross Infection; Female; HIV Infections; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine; Risk Factors; Travel; United States; Vaccination; Vaccines, Inactivated | 1997 |
Advisory Committee on Immunization Practices issues recommendations for the 1997-98 influenza season.
Topics: Amantadine; Antiviral Agents; Humans; Immunization Schedule; Influenza, Human; Rimantadine; United States; Viral Vaccines | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
A new antiviral agent for influenza--is there a clinical niche?
Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 1997 |
Influenza: immunization/prophylaxis for children, adults, and older adults. CDC Advisory Committee on Immunization Practices.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Female; Humans; Immunization Schedule; Infant; Influenza Vaccines; Influenza, Human; Middle Aged; Pregnancy; Rimantadine | 1997 |
Outbreaks of influenza A and B in a highly immunized nursing home population.
Topics: Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Disease Outbreaks; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Nursing Homes; Orthomyxoviridae; Population Surveillance; Prospective Studies; Rimantadine; Vaccination; Wisconsin | 1997 |
[Antiviral prophylaxis and treatment of influenza].
Topics: Amantadine; Antiviral Agents; Haemophilus Vaccines; Humans; Influenza Vaccines; Influenza, Human; Rimantadine | 1998 |
Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Models, Theoretical; Rimantadine; Treatment Outcome | 1998 |
[Comparative analysis of effects of adapromine, midantan, and bromantane on the bioelectric activity of the rat brain].
Topics: Amantadine; Animals; Brain; Central Nervous System Stimulants; Electroencephalography; Male; Rats; Rimantadine | 1998 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Contraindications; Humans; Immunization Programs; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Polyradiculoneuropathy; Rimantadine; Vaccination; Vaccines, Inactivated | 1998 |
Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults.
Topics: Adult; Amantadine; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Leukemia; Middle Aged; Opportunistic Infections; Rimantadine | 1998 |
Long-term stability of the anti-influenza A compounds--amantadine and rimantadine.
Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Drug Stability; Humans; Influenza A virus; Influenza, Human; Rimantadine; Time Factors; Viral Plaque Assay | 1998 |
[Report on the therapeutic use of rimantadine and amantadine].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Homes for the Aged; Hospitalization; Humans; Influenza, Human; Middle Aged; Rimantadine | 1992 |
Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists.
Topics: Administration, Inhalation; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Orthomyxoviridae; Pyrans; Rimantadine; Sialic Acids; Time Factors; Zanamivir | 1999 |
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost of Illness; Cross Infection; Disease Outbreaks; Female; Humans; Infant; Infant, Newborn; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Rimantadine; Risk Factors; Vaccination | 1999 |
Amantadine and rimantadine have no direct inhibitory effects against hepatitis C viral protease, helicase, ATPase, polymerase, and internal ribosomal entry site-mediated translation.
Topics: Adenosine Triphosphatases; Amantadine; Dose-Response Relationship, Drug; Endopeptidases; Hepacivirus; Protein Biosynthesis; Rimantadine; RNA Helicases; RNA-Dependent RNA Polymerase; Viral Matrix Proteins; Viral Proteins | 2000 |
Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Central Nervous System Diseases; Female; Homes for the Aged; Humans; Influenza A virus; Influenza, Human; Male; Neurologic Examination; Nursing Homes; Rimantadine; Risk Factors | 2000 |
Flu-fighting options: decisions, decisions....
Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2000 |
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs.
Topics: Amantadine; Animals; Antigens, Viral; Antiviral Agents; Birds; Drug Resistance, Microbial; Europe; Genes, Viral; HN Protein; Hong Kong; Humans; Infant; Influenza A virus; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phylogeny; Rimantadine; Swine | 2001 |
How to beat the flu: the latest options as a vaccine shortage looms.
Topics: Acetamides; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Device Approval; Drug Costs; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Risk Factors; Sialic Acids; United States; United States Food and Drug Administration | 2000 |
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices.
Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Selection; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2001 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.
Topics: alpha-Cyclodextrins; Amantadine; Antiviral Agents; beta-Cyclodextrins; Cyclodextrins; Electric Conductivity; Electrophoresis, Capillary; Memantine; Rimantadine | 2002 |
Influenza surveillance with rapid diagnostic tests.
Topics: Acetamides; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Population Surveillance; Rimantadine; United States | 2002 |
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Risk Factors; Sialic Acids; United States; Vaccination; Zanamivir | 2002 |
Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.
Topics: Amantadine; Animals; Antiviral Agents; Disease Outbreaks; Enzyme Inhibitors; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; History, 20th Century; Humans; Influenza A virus; Influenza, Human; Male; Mice; Mice, Inbred BALB C; Neuraminidase; Recombination, Genetic; Rimantadine; Viral Matrix Proteins; Virulence | 2002 |
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir | 2003 |
[Treatment of influenza in children].
Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2003 |
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.
Topics: Amantadine; Animals; Antiviral Agents; Chick Embryo; Drug Evaluation, Preclinical; Guanidines; Influenza A virus; Orthomyxoviridae Infections; Pyrans; Rimantadine; Sialic Acids; Survival Analysis; Zanamivir | 2004 |
Avian influenza should be ruffling our feathers.
Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease Outbreaks; Guanidines; Humans; Influenza in Birds; Influenza Vaccines; Influenza, Human; International Cooperation; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; World Health Organization; Zanamivir | 2004 |
Antiviral drugs for prophylaxis and treatment of influenza.
Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Rimantadine; Vaccination | 2004 |
Antiviral drugs for prophylaxis and treatment of influenza.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Prognosis; Rimantadine; Risk Assessment; Treatment Outcome; Vaccination | 2005 |
I wish to comment on several points in the recent "Guidelines".
Topics: Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Rimantadine; Treatment Outcome | 2005 |
Simultaneous determination of amantadine and rimantadine by HPLC in rat plasma with pre-column derivatization and fluorescence detection for pharmacokinetic studies.
Topics: Amantadine; Animals; Chromatography, High Pressure Liquid; Fluorescent Dyes; Kinetics; Male; Mercaptoethanol; o-Phthalaldehyde; Rats; Rats, Wistar; Reproducibility of Results; Rimantadine | 2005 |
Statement on travel, influenza, and prevention.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Travel | 2005 |
Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.
Topics: Amantadine; Chromatography, Liquid; Dansyl Compounds; Melanins; Memantine; Reproducibility of Results; Rimantadine | 2005 |
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanidines; Influenza A virus; Influenza in Birds; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2006 |
Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.
Topics: 4-Chloro-7-nitrobenzofurazan; Amantadine; Binding, Competitive; Calibration; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Memantine; Phosphates; Reproducibility of Results; Rimantadine; Sodium Chloride | 2006 |
Antiviral drugs for prophylaxis and treatment of influenza.
Topics: Adolescent; Amantadine; Antiviral Agents; Child; Child, Preschool; Humans; Infant; Influenza Vaccines; Influenza, Human; Neuraminidase; Rimantadine | 2005 |
Antiviral resistance in influenza viruses--implications for management and pandemic response.
Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Neuraminidase; Nucleic Acid Synthesis Inhibitors; Rimantadine; Viral Matrix Proteins; Virus Replication | 2006 |
[Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Rimantadine | 2006 |
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.
Topics: Amantadine; Amino Acid Substitution; Animals; Antiviral Agents; Asia; Birds; Drug Resistance, Viral; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Rimantadine | 2006 |
Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections.
Topics: Amantadine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Humans; Neuraminidase; Orthomyxoviridae Infections; Ribavirin; Rimantadine | 2006 |
Recommended composition of influenza virus vaccines for use in the 2007 influenza season.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Rimantadine | 2006 |
Amantadine may be lifesaving in severe influenza A.
Topics: Amantadine; Antiviral Agents; Dilatation; Disease Outbreaks; Humans; Influenza A virus; Influenza, Human; Rimantadine | 2006 |
Antiviral management of seasonal and pandemic influenza.
Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Neuraminidase; Oseltamivir; Rimantadine; Seasons; Zanamivir | 2006 |
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus].
Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir | 2006 |
New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma.
Topics: Amantadine; Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Male; Memantine; Molecular Structure; Rats; Rats, Sprague-Dawley; Rimantadine; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2007 |
Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Global Health; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Microbial Sensitivity Tests; Phylogeny; Rimantadine; Sentinel Surveillance | 2007 |
Design, synthesis, and trypanocidal activity of new aminoadamantane derivatives.
Topics: Adamantane; Amantadine; Animals; Parasitic Sensitivity Tests; Rimantadine; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei | 2008 |
Influenza.
Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mass Vaccination; Oseltamivir; Rimantadine; Zanamivir | 2008 |
How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
Topics: Amantadine; Antiviral Agents; Binding Sites; Hydrogen Bonding; Influenza A virus; Ion Transport; Protons; Rimantadine; Solvents; Viral Matrix Proteins; Water | 2008 |
Design and synthesis of bioactive 1,2-annulated adamantane derivatives.
Topics: Amantadine; Animals; Antiviral Agents; Drug Design; Influenza A Virus, H3N2 Subtype; Orthomyxoviridae Infections; Ribavirin; Rimantadine; Swine; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; Viral Matrix Proteins | 2008 |
Antivirals and influenza: frequency of resistance.
Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir | 2008 |
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication | 2008 |
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.
Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir | 2009 |
Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
Topics: Amantadine; Antiviral Agents; Binding Sites; Crystallography, X-Ray; Drug Resistance, Viral; Influenza A virus; Ion Channel Gating; Magnetic Resonance Spectroscopy; Models, Chemical; Rimantadine; Viral Matrix Proteins | 2009 |
Amantadine inhibits platelet-activating factor induced clathrin-mediated endocytosis in human neutrophils.
Topics: Amantadine; Antigens, CD1; Clathrin; Endocytosis; Enzyme Activation; Humans; In Vitro Techniques; NADPH Oxidases; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Rimantadine; Signal Transduction | 2009 |
[Do we really need antiflu virus medication?].
Topics: Amantadine; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Enzyme Inhibitors; Humans; Immunosuppression Therapy; Influenza, Human; Neuraminidase; Program Evaluation; Reproducibility of Results; Rimantadine | 2009 |
Update: influenza activity - United States, August 30-October 31, 2009.
Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Hospitalization; Humans; Infant; Infant, Newborn; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Outpatients; Pneumonia; Population Surveillance; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; United States | 2009 |
Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications.
Topics: Amantadine; Antiviral Agents; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Influenza, Human; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Rimantadine | 2010 |
Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus.
Topics: Amantadine; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Hydrogen-Ion Concentration; Influenza A virus; Ion Channels; Micelles; Models, Molecular; Molecular Dynamics Simulation; Nuclear Magnetic Resonance, Biomolecular; Protein Structure, Quaternary; Protons; Rimantadine; Viral Matrix Proteins | 2011 |
Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.
Topics: Amantadine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Evolution, Molecular; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Iran; Molecular Sequence Data; Mutation; Neuraminidase; Phylogeny; Polymerase Chain Reaction; Rimantadine; Sequence Analysis, DNA; Viral Matrix Proteins | 2010 |
Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
Topics: Amantadine; Antifungal Agents; Antiviral Agents; Blotting, Western; Electroporation; Hepacivirus; Hepatitis C; Humans; Hydrogen-Ion Concentration; Ion Channels; Kidney; Lipid Bilayers; Macrolides; Mutation; Protons; Rimantadine; RNA, Viral; Subcellular Fractions; Transcription, Genetic; Viral Proteins; Virion; Virus Internalization; Virus Replication | 2010 |
Quantitative analysis of influenza M2 channel blockers.
Topics: Amantadine; Animals; Antiviral Agents; Blotting, Western; Chemistry, Pharmaceutical; Crystallography, X-Ray; Escherichia coli; Humans; Influenza A Virus, H1N1 Subtype; Mutation; Plasmids; Protein Structure, Tertiary; Rimantadine; Time Factors; Viral Matrix Proteins | 2011 |
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
Topics: Adamantane; Amantadine; Antiviral Agents; Binding Sites; Drug Resistance, Viral; Humans; Ion Channels; Mutation; Rimantadine; Static Electricity; Viral Matrix Proteins | 2011 |
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir | 2011 |
Discovery of potential M2 channel inhibitors based on the amantadine scaffold via virtual screening and pharmacophore modeling.
Topics: Amantadine; Antiviral Agents; Binding Sites; Drug Evaluation, Preclinical; Hydrogen Bonding; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Membrane Transport Modulators; Models, Molecular; Rimantadine; Structure-Activity Relationship; Thermodynamics; User-Computer Interface; Viral Matrix Proteins | 2011 |
The involvement of a Na⁺- and Cl⁻-dependent transporter in the brain uptake of amantadine and rimantadine.
Topics: Amantadine; Amino Acid Transport Systems; Animals; Blood-Brain Barrier; Blotting, Western; Brain; Humans; Mice; Rimantadine | 2012 |
Determination of amantadine and rimantadine using a sensitive fluorescent probe.
Topics: Amantadine; Analgesics, Non-Narcotic; Antiviral Agents; Fluorescent Dyes; Limit of Detection; Rimantadine; Spectrometry, Fluorescence | 2012 |
Rimantadine and 2-adamantanamine elicit local anesthesia to cutaneous nociceptive stimuli in a rat model.
Topics: Amantadine; Anesthesia, Local; Anesthetics, Local; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Molecular Structure; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reflex; Rimantadine; Skin | 2014 |
Exploring the proton conductance and drug resistance of BM2 channel through molecular dynamics simulations and free energy calculations at different pH conditions.
Topics: Amantadine; Drug Resistance, Viral; Hydrogen-Ion Concentration; Molecular Dynamics Simulation; Protons; Rimantadine; Structure-Activity Relationship; Thermodynamics; Viral Proteins | 2013 |
Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants.
Topics: Amantadine; Animals; Antiviral Agents; Cell Line; Dogs; Drug Carriers; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Orthomyxoviridae Infections; Polyglutamic Acid; Polymers; Rimantadine | 2013 |
Determination of amantadine and rimantadine in chicken muscle by QuEChERS pretreatment method and UHPLC coupled with LTQ Orbitrap mass spectrometry.
Topics: Amantadine; Animals; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Least-Squares Analysis; Limit of Detection; Mass Spectrometry; Meat; Muscle, Skeletal; Reproducibility of Results; Rimantadine | 2013 |
The effect of intravenous sulfobutylether7 -β-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds.
Topics: Amantadine; Animals; beta-Cyclodextrins; Drug Interactions; Erythrocytes; Injections, Intravenous; Male; Memantine; Models, Biological; Protein Binding; Rats, Sprague-Dawley; Rimantadine | 2015 |
The influenza viruses.
Topics: Amantadine; Animals; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Pandemics; Rimantadine; Zoonoses | 2015 |
Investigation of the free energy profiles of amantadine and rimantadine in the AM2 binding pocket.
Topics: Amantadine; Amino Acid Sequence; Amino Acid Substitution; Binding Sites; Molecular Docking Simulation; Molecular Sequence Data; Protein Binding; Rimantadine; Viral Matrix Proteins | 2016 |
Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells.
Topics: Amantadine; Apoptosis; Caspase 1; Dendritic Cells; Humans; Imidazoles; Inflammasomes; Influenza A virus; Interferons; Interleukin-1; Ion Transport; Ions; Monocytes; NLR Family, Pyrin Domain-Containing 3 Protein; Rimantadine; Signal Transduction; Toll-Like Receptors; Up-Regulation | 2016 |
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
Topics: Amantadine; Antibody-Dependent Enhancement; Antiviral Agents; Coronavirus Infections; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Picornaviridae Infections; Respiratory Tract Infections; Rimantadine; Severe Acute Respiratory Syndrome; Texas; Virus Replication | 2016 |
[Determination of amantadine and rimantadine residues in egg and chicken samples by dispersive solid phase extraction purification-ultra high performance liquid chromatography-tandem mass spectrometry].
Topics: Amantadine; Animals; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Eggs; Food Contamination; Meat; Rimantadine; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.
Topics: Amantadine; Antiviral Agents; Blotting, Western; Genotype; HEK293 Cells; Hemadsorption; Hepacivirus; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Patch-Clamp Techniques; Recombinant Proteins; Rimantadine; Transfection; Viral Proteins | 2016 |
Chromatography column comparison and rapid pretreatment for the simultaneous analysis of amantadine, rimantadine, acyclovir, ribavirin, and moroxydine in chicken muscle by ultra high performance liquid chromatography and tandem mass spectrometry.
Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Biguanides; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Meat; Morpholines; Ribavirin; Rimantadine; Tandem Mass Spectrometry | 2016 |
Preparation of a monoclonal antibody against amantadine and rimantadine and development of an indirect competitive enzyme-linked immunosorbent assay for detecting the same in chicken muscle and liver.
Topics: Amantadine; Animals; Antibodies, Monoclonal; Chickens; Drug Residues; Enzyme-Linked Immunosorbent Assay; Limit of Detection; Liver; Muscles; Rimantadine | 2017 |
Dispersive micro solid phase extraction of amantadine, rimantadine and memantine in chicken muscle with magnetic cation exchange polymer.
Topics: Adsorption; Amantadine; Animals; Antiviral Agents; Cations; Chickens; Chromatography, High Pressure Liquid; Dopamine Agents; Food Contamination; Limit of Detection; Magnets; Mass Spectrometry; Memantine; Muscles; Polymers; Poultry; Rimantadine; Solid Phase Extraction | 2017 |
Accounting for apparent deviations between calorimetric and van't Hoff enthalpies.
Topics: Algorithms; Amantadine; beta-Cyclodextrins; Calorimetry; Energy Transfer; Hot Temperature; Kinetics; Rimantadine; Thermodynamics | 2018 |
Simultaneous determination of amantadine and rimantadine in feed by liquid chromatography-Qtrap mass spectrometry with information-dependent acquisition.
Topics: Amantadine; Animal Feed; Animals; Antiviral Agents; Chickens; Chromatography, High Pressure Liquid; Drug Residues; Food Contamination; Hazard Analysis and Critical Control Points; Limit of Detection; Mass Spectrometry; Rimantadine; Solid Phase Extraction | 2018 |
Channel activity of mirror-image M2 proton channel of influenza A virus is blocked by achiral or chiral inhibitors.
Topics: Amantadine; Antiviral Agents; Biological Transport; Hydrogen; Influenza A virus; Ion Channels; Rimantadine; Viral Matrix Proteins | 2019 |
Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
Topics: Adamantane; Amantadine; Antiviral Agents; Cells, Cultured; Drug Design; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Rimantadine; Viral Matrix Proteins; Viral Proteins | 2018 |
Increased Dissociation of Adamantanamines in Influenza A M2 S31N with Partial Block by Rimantadine.
Topics: Amantadine; Antiviral Agents; Dissociative Disorders; Humans; Influenza, Human; Rimantadine; Viral Matrix Proteins | 2020 |
Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
Topics: Amantadine; Amino Acid Sequence; Antiviral Agents; Cell Survival; HEK293 Cells; Hepacivirus; Humans; Patch-Clamp Techniques; Rimantadine; Viral Proteins; Virus Assembly; Virus Release | 2021 |
Development of a molecularly imprinted microspheres-based microplate fluorescence method for detection of amantadine and rimantadine in chicken.
Topics: Amantadine; Animals; Chickens; Microspheres; Molecular Imprinting; Molecular Structure; Muscles; Rimantadine; Spectrometry, Fluorescence | 2021 |
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
Topics: A549 Cells; Adenosine Monophosphate; Alanine; Amantadine; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Denmark; Drug Repositioning; Humans; Ion Channels; Memantine; Rimantadine; SARS-CoV-2; Vero Cells | 2021 |
Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2.
Topics: Amantadine; Amiloride; Antiviral Agents; Ion Channels; Rimantadine; SARS-CoV-2; Viral Proteins | 2021 |
Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
Topics: Amantadine; Antiviral Agents; Autophagy; Cell Line; Hepatitis A; Hepatitis A Antibodies; Hepatitis A virus; Humans; Proteomics; Rimantadine; Virus Replication | 2022 |
[Determination of amantadine, rimantadine and dimethylamantadine residues in poultry by ultra-performance liquid chromatography-tandem mass spectrometry].
Topics: Amantadine; Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Food Contamination; Poultry; Rimantadine; Tandem Mass Spectrometry | 2023 |
Metabolic profiling to evaluate the impact of amantadine and rimantadine on the secondary metabolism of a model organism.
Topics: Adamantane; Amantadine; Metabolic Clearance Rate; Rimantadine; Secondary Metabolism | 2023 |